Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascu...Show More
peer of
Metrics
marketSTOCKS
msh_idCOM:MARKSANSPHARMA
localein
websitehttps://www.marksanspharma.com/
ipo_date2002-07-19
primary_stock_msh_idNSE:MARKSANS
source_refaf80bb36-edec-466b-9ab4-dedd30faadda
products_or_servicesFinished dosage pharmaceutical formulations, health and wellness products, consumer self-care products, prescription therapeutic segments.